Infectious Disease
HIV 1/2 Rapid Test
Detects HIV-1/2 antibodies. colloidal-gold. Specimen: WB / S / P.
| Target / Analyte | HIV-1/2 antibodies |
|---|---|
| Disease / Indication | HIV/AIDS |
| Series | Infectious Disease |
| Method | colloidal-gold |
| Specimen | WB / S / P |
| Regulatory | Non-CE / registration in progress |
| OEM/ODM | Available — private label & custom panel |
Direct Answer
This rapid test detects HIV-1/2 antibodies in WB / S / P to support HIV/AIDS. It is a colloidal-gold screening test — a reactive result is presumptive and should be confirmed per the intended use.
Intended Use
Detection of antibodies to HIV-1 and HIV-2 in blood.
Clinical Context
HIV antibody tests detect immune response to infection; standard first-line screening. WHO testing strategies use serial antibody tests with confirmation.
Test Principle
Colloidal-gold immunochromatography (lateral flow). The device captures the target analyte (antigen or antibody) on a membrane via labeled antibodies, producing a visible test line within minutes. Qualitative or semi-quantitative, intended as a screening/triage aid — not a replacement for confirmatory laboratory testing.
Limitations
A reactive result is presumptive and must be confirmed per national algorithm; antibody tests miss very early infection (window period).
Procurement
Specimen: whole blood / serum / plasma. Format: cassette / dipstick. Registration in progress (Non-CE per current catalog).
Interpretation
| Result | Lines | Meaning |
|---|---|---|
| Positive | Test + control line | Target detected (presumptive positive) |
| Negative | Control line only | Below cut-off / not detected |
| Invalid | No control line | Repeat with a new device |
Documentation & quotation — datasheet, IFU, MOQ and OEM/ODM options on request.
Last reviewed: 2026-09-12